// App-Quantinova.ai

1673P : Ex vivo expansion of circulating tumor cells for individualized drug susceptibility in patients with advanced or recurrent oesophageal cancer

Researchers

Presenter

  • V.Kumar

Principal Investigators

  • R.C.Sagar

  • P.Kumar

Medical Centers

  • Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India

  • Bioinformatics, Institute of Bioinfomatics, Bangalore, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A